Imovax Polio Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Indications/Uses Dosage/Direction for Use Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Inactivated types 1, 2, 3 poliomyelitis vaccine: Type 1 (Mahoney) 40 DU, type 2 (MEF-I) 8 DU, type 3 (Saukett) 32 DU

Indications/Uses

Prevention of poliomyelitis in infants, childn & adults for primary vaccination & booster.

Click to view Imovax Polio detailed prescribing information

Dosage/Direction for Use

IM/SC Non-vaccinated adult 2 successive 0.5 mL inj at interval of 2 mth, followed by a booster dose 8-12 mth after the 1st inj. Childn 1 dose at the age of 2 mth & 1 dose at the age of 4 mth, followed by a booster dose at the age of 11 mth.

Click to view Imovax Polio detailed prescribing information

Contraindications

Hypersensitivity to poliomyelitis vaccine, neomycin, streptomycin, polymyxin B. Postpone vaccination in case of fever or acute disease.

Click to view Imovax Polio detailed prescribing information

Special Precautions

Blood disorders eg, thrombocytopenia or clotting disorder; taking treatment that suppresses immune defences or presenting w/ an immune deficiency disorder (postpone vaccination). Present w/ chronic immunodeficiency eg, infection w/ AIDS virus (HIV). Do not inj intravascularly.

Click to view Imovax Polio detailed prescribing information

Use In Pregnancy & Lactation

Click to view Imovax Polio detailed prescribing information

Adverse Reactions

Inj site pain, fever (≥38.1°C). Inj site redness.

Click to view Imovax Polio detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Imovax Polio detailed prescribing information

Storage

View Imovax Polio storage conditions for details to ensure optimal shelf-life.

Description

View Imovax Polio description for details of the chemical structure and excipients (inactive components).

MIMS Class

Vaccines, Antisera & Immunologicals

ATC Classification

J07BF03 - poliomyelitis, trivalent, inactivated, whole virus ; Belongs to the class of poliomyelitis viral vaccines.

Regulatory Classification

Presentation/Packing

Form

Imovax Polio inj

Packing/Price

(multidose vial) 0.5 mL x 1's (P420/vial); (pre-filled syringe) 0.5 mL x 1's (P350/pre-filled syringe)

Imovax Polio

vaccine, poliomyelitis

Manufacturer:

Sanofi Pasteur

Distributor:

Zuellig